Going the Extra Mile to Turn Science into Reality for Patients in Europe
The pandemic proved that necessity truly is the mother of invention and furthermore demonstrated the critical need to ensure a
Read moreHealth
For a pharmaceutical strategy promoting health security
The pandemic has put Europe in the mirror, and forced us to reorganise our priorities. We have learned from our
Read more
Strengthening Europe’s capacity to anticipate and respond rapidly to cross-border health emergencies
In the past 10 years, the world has witnessed some of the deadliest outbreaks of infectious diseases in modern times,
Read more
Ensuring a robust and safe supply chain for pharmaceuticals in Europe
Until March 2020 and the emergence of the COVID-19 pandemic in Europe, the concepts of ‘sovereignty’ and ‘strategic autonomy’, used
Read more
European Union needs reliable and secure access to health data to build strategic autonomy
When planning strategic autonomy in health, policymakers face a problem known in behavioural science as hyperbolic discounting. This means that
Read more
Reinforcing Europe as a centre for pharmaceutical innovation
Europe is home to a rich innovation ecosystem with start-ups, world-class research institutions, top universities for life sciences and many
Read more
Pharmaceutical sector – how to truly achieve strategic resilience
A strong Union needs a strong industrial sector to promote competitiveness, create jobs and guarantee a high quality of life.
Read more
The EU’s supportive role in managing public health crises and cross-border threats
As the COVID-19 pandemic unfolded, the European Union (EU), its Member States and institutions swiftly managed to work together and
Read more